Skip to main content
. 2023 Jun 7;18:1057–1066. doi: 10.2147/COPD.S404039

Table 1.

Characteristics of Patients with COPD with or Without Triple Therapy

Triple Therapy (n=19,358) Without Triple Therapy (n=19,358) p value
N % N %
Number of deaths 4832 24.96 3269 16.89 <0.0001
Age
 40–59 5044 26.06 5044 26.06 1.0000
 60–74 9618 49.68 9618 49.68
 ≧75 4696 24.26 4696 24.26
Sex
 Male 16433 84.89 16433 84.89 1.0000
 Female 2925 15.11 2925 15.11
Exacerbations
 No exacerbations 5076 26.22 5076 26.22 1.0000
 Ever had exacerbations 14,282 73.78 14,282 73.78
Comorbidities
 Acute respiratory failure 611 3.16 479 2.47 <0.0001
 Pneumonia 4953 25.59 4629 23.91 0.0001
 Lung cancer 458 2.37 293 1.51 <0.0001
 Thoracic malignancies 507 2.62 344 1.78 <0.0001
 Bronchiectasis 974 5.03 526 2.72 <0.0001
 Hypertensive diseases 8734 45.12 10,155 52.46 <0.0001
 Ischemic heart disease 4343 22.44 4546 23.48 0.0142
 Heart failure 2044 10.56 1425 7.36 <0.0001
 Stroke 1120 5.79 1913 9.88 <0.0001
 Myocardial infarction 1547 7.99 1572 8.12 0.6406
 Cancer (except lung and thoracic) 1127 5.82 1045 5.40 0.0701
 Diabetes mellitus 2968 15.33 4174 21.56 <0.0001
 Renal diseases 675 3.49 850 4.39 <0.0001
 Dementia/Alzheimer’s disease 258 1.33 620 3.20 <0.0001